Published Research Shows Initial Results from SARS-CoV-2 Surveillance Studies Support U.S. Public Health Initiatives
INNOVATIVE RESPONSE SUPPORTS FUTURE RESPONSES AGAINST SIMILAR PANDEMIC THREATS First results from the CDC SARS-CoV-2…
News
Corent and IBM Red Hat Achieve Finalist Status for “Best Platform as a Service” in the CODiE Awards
ALISO VIEJO, Calif.–(BUSINESS WIRE)–#CODiE—Corent Technology congratulates the teams at Corent and IBM Red Hat who…
Wolters Kluwer named 2022 SIIA CODiE award finalist in 7 categories
Lippincott CoursePoint+, vSim for Nursing, and Lippincott Skills earn nods from industry leaders WALTHAM, Mass.–(BUSINESS…
Rubix Token Listed on Europe’s Whitebit Exchange
Crypto site is the latest to feature the Rubix Proofchain asset WASHINGTON–(BUSINESS WIRE)–Rubix Blockchain Pte…
A Global Medical Device Manufacturer and A Midwest Investment Firm Expand and Increase Spend with CynergisTek’s IT Audit Group with Two Six-Figure Contracts
CynergisTek announces its IT Audit Group expands Professional Service agreements for a medical device manufacturer…
KBRA Assigns Preliminary Ratings to CSMC 2022-NQM3 Trust (CSMC 2022-NQM3)
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to seven classes of mortgage pass-through notes from CSMC…
The World’s First Attachment Tokenization Solution For Google Workspace and Gmail Launches In Google Chrome Store
Document GPS email extension is a revolutionary tool to monitor and control email attachments. Give…
Metropolitan Announces Mandatory Conservation Plan Restricting Outdoor Watering to One Day a Week in Response to Drought Crisis
Water Shortage Emergency declared in communities in Los Angeles, San Bernardino and Ventura counties, home…
Holly Gordon Joins Crusoe Energy Systems as VP of Public Engagement & ESG, Hui Wen Chan Joins as Head of Sustainability
Crusoe Expands Executive Team, Adds Experienced Government Affairs, Public Relations, ESG and Sustainability Capabilities DENVER–(BUSINESS…
eternalHealth Expands Executive Team, Hires Chief Compliance Officer, Chief Medical Officer, and Vice President of Finance
BOSTON–(BUSINESS WIRE)–eternalHealth, a consumer-centric Medicare Advantage Plan in Massachusetts, recently announced that three senior-level executives…
Telent arms the AMRC with the 5G Private Network tools to unlock Industry 4.0 potential for its customers
The Nokia Digital Automation Cloud application platform will help the AMRC solve complex industrial and…
NordPass Business introduces free 30-day trial
Business customers can now test out the password manager without commitment LONDON, April 27, 2022…
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., to Present SP-102 (SEMDEXA™) Efficacy and Safety Data from its Pivotal Phase 3 Clinical Trial Program for Sciatica Pain Management at the 24th Annual Meeting of American Society of Interventional Pain Physicians (ASIPP) in Las Vegas, NV.
PALO ALTO, Calif., April 27, 2022 (GLOBE NEWSWIRE) — Scilex Holding Company (“Scilex”), a nearly…
AXIM Develops Quantitative Rapid Diagnostic Test for Lacritin; Now Boasts Four Dry Eye Disease Point-of-Care Biomarker Tests
SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or…
Rakovina Therapeutics Inc. Announces 2021 Financial Results and Provides Corporate Update
VANCOUVER, British Columbia, April 27, 2022 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV, the…
Vir Biotechnology Announces New Data From the MARCH Hepatitis B Trial, Unveils New Hepatitis D Clinical Program and Highlights Broad Hepatitis Portfolio at Virtual Hepatitis Portfolio R&D Day
– Strategic clinical program for hepatitis B and D with potential for multiple value drivers…
Panbela to Host Virtual R&D Day
MINNEAPOLIS, April 27, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for T2Biothreat Panel
LEXINGTON, Mass., April 27, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
BioCorRx Begins Recruitment for Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
ANAHEIM, CA, April 27, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”),…
SCYNEXIS Presents Data Analyses Showing Ibrexafungerp’s Potential to Fight Invasive Candidiasis and Candidemia, Including Infections Caused by Candida Auris, During the 32nd Annual European Congress of Clinical Microbiology & Infectious Diseases
New interim analysis of the Phase 3 CARES study showed complete or partial response in…